Antibodies against EV71 VLPs neutralize infection by inhibiting both pre-attachment and post-attachment steps, informing future vaccine development.
Authors
No takes yet. Share an insight, caveat, or question.
Supports conserved epitope targeting for EV71 VLP vaccines; leaves open in vivo protection and human translation.
Ku et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: